References
- Isoardi KZ, Kulawickrama S, Isbister GK. Severe phenibut poisoning: an adolescent case cluster. J Paediatr Child Health. 2020;56(2):330–331. Feb
- Jouney EA. Phenibut (β-phenyl-γ-aminobutyric acid): an easily obtainable “dietary supplement” with propensities for physical dependence and addiction. Curr Psych Rep. 2019;21:23.
- Graves JM, Dilley J, Kubsad S, et al. Notes from the field: Phenibut exposures reported to poison centers - United States, 2009-2019. MMWR Morb Mortal Wkly Rep. 2020;69(35):1227–1228.
- US Food and Drug Administration. Phenibut in dietary supplements. April 29, 2019. Available at: https://www.fda.gov/food/dietary-supplement-products-ingredients/phenibut-dietary-supplements. [accessed July 13, 2021]
- Downes MA, Berling IL, Mostafa A, et al. Acute behavioural disturbance associated with phenibut purchased via an internet supplier. Clin Toxicol (Phila)). 2015;53(7):636–638.
- McCabe DJ, Bangh SA, Arens AM, Cole JB. Phenibut exposures and clinical effects reported to a regional poison center. Am J Emerg Med. 2019;37(11):2066–2071.
- Avula B, Bae JY, Chittiboyina AG, et al. Liquid chromatography-quadrupole time of flight mass spectrometric method for targeted analysis of 111 nitrogen-based compounds in weight loss and ergogenic supplements. J Pharm Biomed Anal. 2019;174:305–323.
- Cohen PA, Avula B, Wang YH, et al. Five unapproved drugs found in cognitive enhancement supplements. Neurol Clin Pract. 2021;11(3):e303–e307.
- Cohen PA, Sharfstein J, Kamugisha A, et al. Analysis of ingredients of supplements in the National Institutes of Health supplement database marketed as containing a novel alternative to anabolic steroids. JAMA Netw Open. 2020;3(4):e202818.
- Cohen PA. The FDA and adulterated supplements-Dereliction of Duty. JAMA Netw Open. 2018;1(6):e183329.
- Cohen PA, Wen A, Gerona R. Prohibited stimulants in dietary supplements after enforcement action by the US Food and Drug Administration. JAMA Intern Med. 2018;178(12):1721–1723.